Involvement of delta and mu opioid receptors in the acute and sensitized locomotor action of cocaine in mice

Peptides

Volumn 48, Issue , 2013, Pages 89-95

  Kotlinska, J H ^a   Gibula Bruzda, E ^a   Witkowska, E ^b   Izdebski, J ^b  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

^b UNIVERSITY OF WARSAW   (Poland)

Author keywords

Cocaine; Deltorphins analogs; Locomotor activity; Mice; Sensitization

Indexed keywords

BETA FUNALTREXAMINE; COCAINE; DEL 6; DELTA OPIATE RECEPTOR; DK 4; MU OPIATE RECEPTOR; NALTRINDOLE; OPIATE AGONIST; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; DRUG POTENTIATION; DRUG SENSITIZATION; DRUG SYNTHESIS; INJECTION; LOCOMOTION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION;

CAVIA; MUS;

COCAINE; DELTORPHINS ANALOGS; LOCOMOTOR ACTIVITY; MICE; SENSITIZATION;

ANIMALS; COCAINE; HUMANS; MICE; MOTOR ACTIVITY; NALTREXONE; OLIGOPEPTIDES; PAIN MEASUREMENT; RECEPTORS, OPIOID, DELTA; RECEPTORS, OPIOID, MU;

EID: 84886917224     PISSN: 01969781     EISSN: 18735169     Source Type: Journal    
DOI: 10.1016/j.peptides.2013.08.009     Document Type: Article

References (62)

1. Adinoff B. Neurobiologic processes in drug reward and addiction. Harv Rev Psychiatry 2004;12:305-20. (Pubitemid 40144218)
2. Aliane V, Pérez S, Nieoullon A, Deniau JM, Kemel ML. Cocaine-induced stereotypy is linked to an imbalance between the medial prefrontal and sensorimotor circuits of the basal ganglia. Eur J Neurosci 2009;30:1269-79.
3. Azaryan AV, Coughlin LJ, Búzás B, Clock BJ, Cox BM. Effect of chronic cocaine treatment on mu- and delta-opioid receptor mRNA levels in dopaminergically innervated brain regions. J Neurochem 1996;66:443-8. (Pubitemid 26036677)
4. Bain GT, Kornetsky C. Naloxone attenuation of the effect of cocaine on rewarding brain stimulation. Life Sci 1987;40:1119-25. (Pubitemid 17025631)
5. Bilsky EJ, Montegut MJ, Delong CL, Reid LD. Opioidergic modulation of cocaine conditioned place preferences. Life Sci 1992;50:85-90.
6. Calenco-Choukroun G, Daugé V, Gacel G, Féger J, Roques BP. Opioid delta agonists and endogenous enkephalins induce different emotional reactivity than mu agonists after injection in the rat ventral tegmental area. Psychopharmacology (Berl) 1991;103:493-502.
7. Ciszewska M, Kwasiborska M, Nowakowski M, Oleszczuk M, Wójcik J, Chung NN, et al. N-(ureidoethyl)amides of cyclic enkephalin analogs. J Pept Sci 2009;15:312-8.
8. Corrigall WA, Coen KM. Opiate antagonists reduce cocaine but not nicotine self-administration. Psychopharmacology (Berl) 1991;104:167-70.
9. DuMars LA, Rodger LD, Kalivas PW. Behavioral cross-sensitization between cocaine and enkephalin in the A10 dopamine region. Behav Brain Res 1988;27:87-91. (Pubitemid 18024682)
10. Haley TJ, Mccormick WG. Pharmacological effects produced by intracerebral injection of drugs in the conscious mouse. Br J Pharmacol Chemother 1957;12:12-5.
11. Hayes AG, Skingle M, Tyers MB. Effect of beta-funaltrexamine on opioid side-effects produced by morphine and U-50, 488H. J Pharm Pharmacol 1985;37:841-3. (Pubitemid 16236958)
12. Heidbreder C, Shoaib M, Shippenberg TS. Differential role of delta-opioid receptors in the development and expression of behavioral sensitization to cocaine. Eur J Pharmacol 1996;298:207-16.
13. Heidbreder CA, Goldberg SR, Shippenberg TS. The kappa-opioid receptor agonist U-69593 attenuates cocaine-induced behavioral sensitization in the rat. Brain Res 1993;616:335-8. (Pubitemid 23200066)
14. Heidbreder CA, Thompson AC, Shippenberg TS. Role of extracellular dopamine in the initiation and long-term expression of behavioral sensitization to cocaine. J Pharmacol Exp Ther 1996;278:490-502. (Pubitemid 27167011)
15. Herz A. Opioid reward mechanisms: a key role in drug abuse. Can J Physiol Pharmacol 1998;76:252-8. (Pubitemid 28337022)
16. Hoffman JA, Klein H, Clark DC, Boyd FT. The effect of entering drug treatment on involvement in HIV-related risk behaviors. Am J Drug Alcohol Abuse 1998;24:259-84. (Pubitemid 28272317)
17. Holaday JW, Long JB, Tortella FC. Evidence for-,- and- opioid binding site interactions in vivo. Fed Proc 1985;44:2860.
18. Houdi AA, Bardo MT, Van Loon GR. Opioid mediation of cocaine-induced hyperactivity and reinforcement. Brain Res 1989;497:195-8. (Pubitemid 19219930)
19. Hurd YL, Herkenham M. Influence of a single injection of cocaine, amphetamine or GBR 12909 on mRNA expression of striatal neuropeptides. Brain Res Mol Brain Res 1992;16:97-104.
20. Jones DN, Bowen WD, Portoghese PS, Holtzman SG. Delta-opioid receptor antagonists attenuate motor activity induced by amphetamine but not cocaine. Eur J Pharmacol 1993;249:167-77.
21. Jutkiewicz EM, Baladi MG, Folk JE, Rice KC, Woods JH. The delta-opioid receptor agonist SNC80 [(+)-4-[alpha(R)-alpha-[(2S,5R)-4-allyl-2,5-dimethyl- 1-piperazinyl]-(3-methoxybenzyl)-N,N-diethylbenzamide] synergistically enhances the locomotor-activating effects of some psychomotor stimulants, but not direct dopamine agonists, in rats. J Pharmacol Exp Ther 2008;324:714-24. (Pubitemid 351185827)
22. Kalivas PW, Duffy P. Effect of acute and daily cocaine treatment on extracellular dopamine in the nucleus accumbens. Synapse 1990;5:48-58. (Pubitemid 20110621)
23. Kitanaka J, Kitanaka N, Hall FS, Uhl GR, Fukushima Y, Sawai T, et al. The selective opioid receptor antagonistβ-funaltrexamine attenuates methamphetamineinduced stereotypical biting in mice. Brain Res 2013;1522:88-98.
24. Kotlinska JH, Gibula-Bruzda E, Pachuta A, Kunce D, Witkowska E, Chung NN, et al. Influence of new deltorphin analogues on reinstatement of cocaine-induced conditioned place preference in rats. Behav Pharmacol 2010;21:638-48.
25. Kotlinska JH, Gibula-Bruzda E, Witkowska E, Chung NN, Schiller PW, Izdebski J. Antinociceptive effects of two deltorphins analogs in the tail-immersion test in rats. Peptides 2013;39:103-10.
26. Kuribara H. Induction of sensitization to hyperactivity caused by morphine in mice: effects of post-drug environments. Pharmacol Biochem Behav 1997;57:341-6. (Pubitemid 27261431)
27. Kuribara H. Modification of cocaine sensitization by dopamine D1 and D2 receptor anatgonists in terms of ambulation in mice. Pharmacol Biochem Behav 1995;51:799-805.
28. Leone P, Pocock D, Wise RA. Morphine-dopamine interaction: ventral tegmental morphine increases nucleus accumbens dopamine release. Pharmacol Biochem Behav 1991;39:469-72.
29. Lesscher HM, Hordijk M, Bondar NP, Alekseyenko OV, Burbach JP, van Ree JM, et al. Mu-opioid receptors are not involved in acute cocaine-induced locomotor activity nor in development of cocaine-induced behavioral sensitization in mice. Neuropsychopharmacology 2005;30:278-85. (Pubitemid 40129479)
30. McDaid J, Dallimore JE, Mackie AR, Mickiewicz AL, Napier TC. Crosssensitization to morphine in cocaine-sensitized rats: behavioral assessments correlate with enhanced responding of ventral pallidal neurons to morphine and glutamate, with diminished effects of GABA. J Pharmacol Exp Ther 2005;313:1182-93. (Pubitemid 40727021)
31. Mori T, Ito S, Narita M, Suzuki T, Sawaguchi T. Combined effects of psychostimulants and morphine on locomotor activity in mice. J Pharmacol Sci 2004;96:450-8. (Pubitemid 40144066)
32. Olive MF, Koenig HN, Nannini MA, Hodge CW. Stimulation of endorphin neurotransmission in the nucleus accumbens by ethanol, cocaine, and amphetamine. J Neurosci 2001;21:RC184.
33. Perrine SA, Sheikh SI, Nwaneshiudu CA, Schroeder JA, Unterwald EM. Withdrawal from chronic administration of cocaine decreases delta opioid receptor signaling and increases anxiety-and depression-like behaviors in the rat. Neuropharmacology 2008;54:355-64.
34. Plunkett LM, Seifen E, Kennedy RH. Effects of morphine pretreatment on cocaine cardiotoxicity in anesthetized guinea-pigs. Arch Int Pharmacodyn Ther 1989;297:60-7. (Pubitemid 19066349)
35. Portoghese PS, Sultana M, Takemori AE. Naltrindole, a highly selective and potent non-peptide delta opioid receptor antagonist. Eur J Pharmacol 1988;146:185-6. (Pubitemid 18030440)
36. Ritz MC, Lamb RJ, Goldberg SR, Kuhar MJ. Cocaine receptors on dopamine transporters are related to self-administration of cocaine. Science 1987;237:1219-23. (Pubitemid 17131228)
37. Robinson TE, Berridge KC. The psychology and neurobiology of addiction: an incentive-sensitization view. Addiction 2000;95:91-118.
38. Sala M, Braida D, Colombo M, Groppetti A, Sacco S, Gori E, et al. Behavioral and biochemical evidence of opioidergic involvement in cocaine sensitization. J Pharmacol Exp Ther 1995;274:450-7.
39. Shippenberg TS, LeFevour A, Thompson AC. Sensitization to the conditioned rewarding effects of morphine and cocaine: differential effects of the kappaopioid receptor agonist U69593. Eur J Pharmacol 1998;345:27-34. (Pubitemid 28179466)
40. Sierra V, Duttaroy A, Lutfy K, Candido J, Billings B, Zito SW, et al. Potentiation of opioid analgesia by cocaine: the role of spinal and supraspinal receptors. Life Sci 1992;50:591-7.
41. Simmons D, Self DW. Role of mu- and delta-opioid receptors in the nucleus accumbens in cocaine-seeking behavior. Neuropsychopharmacology 2009;34:1946-57.
42. Sivam SP. Cocaine selectively increases striatonigral dynorphin levels by a dopaminergic mechanism. J Pharmacol Exp Ther 1989;250:818-24. (Pubitemid 19246687)
43. Smith MA, Gordon KA, Craig CK, Bryant PA, Ferguson ME, French AM, et al. Interactions between opioids and cocaine on locomotor activity in rats: influence of an opioid's relative efficacy at the mu receptor. Psychopharmacology (Berl) 2003;167:265-73. (Pubitemid 36712973)
44. Smith MA, Greene-Naples JL, Felder JN, Iordanou JC, Lyle MA, Walker KL. The effects of repeated opioid administration on locomotor activity: II. Unidirectional cross-sensitization to cocaine. J Pharmacol Exp Ther 2009;330:476-86.
45. Spangler R, Unterwald EM, Kreek MJ. 'Binge' cocaine administration induces a sustained increase of prodynorphin mRNA in rat caudate-putamen. Brain Res Mol Brain Res 1993;19:323-7.
46. Spealman RD, Bergman J. Modulation of the discriminative stimulus effects of cocaine by mu and kappa opioids. J Pharmacol Exp Ther 1992;261:607-15.
47. Suzuki T, Mori T, Funada M, Misawa M, Nagase H. Attenuation of the discriminative stimulus properties of cocaine by delta-opioid receptor antagonists. Eur J Pharmacol 1994;263:207-11. (Pubitemid 24290274)
48. Takemori AE, Ho BY, Naeseth JS, Portoghese PS. Nor-binaltorphimine, a highly selective kappa-opioid antagonist in analgesic and receptor binding assays. J Pharmacol Exp Ther 1988;246:255-8.
49. Tang XC, McFarland K, Cagle S, Kalivas PW. Cocaine-induced reinstatement requires endogenous stimulation of mu-opioid receptors in the ventral pallidum. J Neurosci 2005;25:4512-20. (Pubitemid 40629141)
50. Taylor MD, de Ceballos ML, Jenner P, Marsden CD. Acute effects of D-1 and D-2 dopamine receptor agonist and antagonist drugs on basal ganglia [Met5]- and [Leu5]-enkephalin and neurotensin content in the rat. Biochem Pharmacol 1991;41:1385-91.
51. Trujillo KA, Smith ML, Guaderrama MM. Powerful behavioral interactions between methamphetamine and morphine. Pharmacol Biochem Behav 2011;99:451-8.
52. Ukai M, Mori E, Kameyama T. Cocaine-like discriminative stimulus properties of the delta-selective opioid receptor agonist, [d-Pen2, l-Pen5]enkephalin, in the rat. Eur J Pharmacol 1993;231:143-4. (Pubitemid 23039557)
53. Unterwald EM, Cuntapay M. Dopamine-opioid interactions in the rat striatum: a modulatory role for dopamine D1 receptors in delta opioid receptor-mediated signal transduction. Neuropharmacology 2000;39:372-81. (Pubitemid 30052926)
54. Unterwald EM, Horne-King J, Kreek MJ. Chronic cocaine alters brain mu opioid receptors. Brain Res 1992;584:314-8.
55. Unterwald EM, Rubenfeld JM, Kreek MJ. Repeated cocaine administration upregulates kappa and mu, but not delta, opioid receptors. Neuroreport 1994;5:1613-6. (Pubitemid 24265254)
56. Waddell AB, Holtzman SG. Modulation of cocaine-induced motor activity in the rat by opioid receptor agonists. Behav Pharmacol 1998;9:397-407.
57. Wang NS, Brown VL, Grabowski J, Meisch RA. Reinforcement by orally delivered methadone, cocaine, and methadone-cocaine combinations in rhesus monkeys: are the combinations better reinforcers. Psychopharmacology (Berl) 2001;156:63-72. (Pubitemid 32646326)
58. Weiss F, Paulus MP, Lorang MT, Koob GF. Increases in extracellular dopamine in the nucleus accumbens by cocaine are inversely related to basal levels: effects of acute and repeated administration. J Neurosci 1992;12:4372-80.
59. Wise RA, Leone P, Rivest R, Leeb K. Elevations of nucleus accumbens dopamine and DOPAC levels during intravenous heroin self-administration. Synapse 1995;21:140-8.
60. Woo SK, Hitzemann RJ, Loh HH. Specific opioid-amphetamine interactions in the caudate putamen. Psychopharmacology (Berl) 1985;85:371-6. (Pubitemid 15123116)
61. Yoo JH, Yang EM, Lee SY, Loh HH, Ho IK, Jang CG. Differential effects of morphine and cocaine on locomotor activity and sensitization in mu-opioid receptor knockout mice. Neurosci Lett 2003;344:37-40. (Pubitemid 36627828)
62. Zieleniak A, Rodziewicz-Motowidło S, Rusak L, Chung NN, Czaplewski C, Witkowska E, et al. Deltorphin analogs restricted via a urea bridge: structure and opioid activity. J Peptide Sci 2008;14:830-7.